Answers are grounded in this paper and cite their sources.
Objectives To characterize longitudinal candidate cytomegalovirus (CMV)-associated T-cell receptor β (TCRβ) clonotype dynamics after haploidentical allogeneic hematopoietic stem cell transplantation (HSCT) and, in an independent intestinal biopsy cohort, to describe tissue immune alterations associated with CMV gastrointestinal disease. Design Single-center exploratory observational study comprising two complementary, unmatched cohorts: longitudinal peripheral-blood TCRβ variable-diversity-joining (V(D)J) sequencing in donor-recipient pairs and transcriptomic digital spatial profiling (DSP) of intestinal biopsies from an independent cohort. Setting Department of Hematology, Chinese PLA General Hospital, Beijing, China. Participants Twelve haploidentical HSCT recipients and their corresponding donors were included in the peripheral immune-repertoire cohort. A separate cohort of eight HSCT recipients contributed intestinal biopsy specimens for DSP (four with CMV gastrointestinal disease and four without CMV gastrointestinal disease). Main outcome measures CMV DNAemia/reactivation, refractory CMV infection, CMV end-organ disease, abundance and donor detectability of candidate CMV-associated TCRβ clonotypes, transcriptomic immune-cell enrichment, and an exploratory immune collapse score (ICS). Results Seven of 12 recipients developed CMV reactivation. Absent or low-abundance donor candidate CMV-associated TCRβ clonotypes and limited early recipient clonotype expansion were observed in several patients with early or refractory CMV complications. Longitudinal trajectories varied substantially between patients, with both transient and progressive increases. In the independent biopsy cohort, CMV gastrointestinal disease was associated with lower expression of immune-related genes, reduced enrichment of several immune-cell signatures, and higher ICS values. Conclusions These small, independent cohorts provide exploratory observations on candidate CMV-associated TCRβ clonotype dynamics and intestinal immune signatures after haploidentical HSCT. The findings are hypothesis-generating and do not establish a blood–tissue relationship, predictive performance, or clinical utility. Validation in larger, multicenter cohorts with paired blood and tissue sampling is required.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: